CHRISTOPHER BACHUSS: Open Payments
NPI 1437147626 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,784 in 150 payments from 30 companies in 2025. Trend: 2023 $3,188 · 2024 $2,838 · 2025 $2,784
Food & beverage: $2,784
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $436 |
| UCB, Inc. | 18 | $328 |
| TG Therapeutics, Inc. | 10 | $230 |
| Lundbeck LLC | 15 | $186 |
| Lilly USA, LLC | 8 | $145 |
| Biogen, Inc. | 6 | $140 |
| ARGENX US, INC. | 4 | $126 |
| EMD Serono, Inc. | 5 | $110 |
| Eisai Inc. | 5 | $103 |
| Alexion Pharmaceuticals, Inc. | 5 | $99 |
Products named: UBRELVY, BRIUMVI, REXULTI, AMYVID, VYVGART HYTRULO, VUMERITY, Leqembi, ULTOMIRIS.
Industry payments across TN — which companies pay providers there.
